In a report released yesterday, Anthony Vendetti from Maxim Group maintained a Buy rating on Applied DNA Sciences (APDN – Research Report), with a price target of $6.00. The company's shares closed last Tuesday at $1.40, close to its 52-week low of $1.08. According to TipRanks.com, Vendetti is a 3-star analyst with an average return of 1.1% and a 34.8% success rate. Vendetti covers the Healthcare sector, focusing on stocks such as Guardion Health Sciences, ReShape Lifesciences, and Dermata Therapeutics. Applied DNA Sciences has an analyst consensus of Moderate Buy, with a price target consensus of $5.00, representing a 233.3% upside. In a report released yesterday, H.C.
https://www.tipranks.com/news/blurbs/maxim-group-thinks-applied-dna-sciences-stock-is-going-to-recover-2?utm_source=advfn.com&utm_medium=referral
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Jan 2023 to Feb 2023 Click Here for more Applied DNA Sciences Charts.
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Feb 2022 to Feb 2023 Click Here for more Applied DNA Sciences Charts.